Dilaudid Dosage
Generic name: hydromorphone (oral)
Brand names: Dilaudid, Exalgo, Hydrostat IR
Drug class: Narcotic analgesics
Medically reviewed by A Ras MD.
Recommended Adult Dosing
Dosage forms: TAB: 2 mg, 4 mg, 8 mg; SOL: 1 mg per mL; INJ (pre-filled syringe): 0.5 mg per 0.5 mL, 1 mg per mL, 2 mg per mL, 4 mg per mL
Dosage Forms Discontinued in US
- [3 mg supp not avail. as brand; see generic]
 
Special Note
- [prescribing info]
 - Info: consider prescribing naloxone if risk of opioid overdose or accidental ingestion
 
Pain, mod-severe
- [PO route, tablet]
 - Dose: individualize dose PO q3-6h prn; Start: 2-4 mg PO q4-6h; Info: in pts converting from other opioids, consider starting 1-2 mg PO q4-6h; use lowest effective dose, shortest effective tx duration; consider low start dose, titrate slowly in pts 65 yo and older; taper total daily dose by no more than 10-25% q2-4wk to D/C if prolonged or long-term use
 
- [PO route, oral solution]
 - Dose: individualize dose PO q3-6h prn; Start: 2.5-10 mg PO q3-6h; Info: in pts converting from other opioids, consider starting 1.25-5 mg PO q3-6h; use lowest effective dose, shortest effective tx duration; consider low start dose, titrate slowly in pts 65 yo and older; taper total daily dose by no more than 10-25% q2-4wk to D/C if prolonged or long-term use
 
- [parenteral route]
 - Dose: 1-4 mg SC/IM/IV q3-6h; Start: 0.2-1 mg IV q2-3h; 1-2 mg SC/IM q2-3h; Info: use lowest effective dose, shortest effective tx duration; consider low start dose, titrate slowly in pts 65 yo and older; taper dose by 25-50% q2-4 days to D/C if prolonged or long-term use
 
- [rectal route]
 - Dose: 3 mg PR q6-8h; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if prolonged or long-term use
 
- [*PCA route]
 - Dose: 0.05-0.4 mg IV q6-20min prn; Start: 0.1-0.5 mg IV x1; Info: basal rate for opioid-experienced pts is up to 0.5 mg/h; dosing varies, refer to institution protocol; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if prolonged or long-term use
 
Renal dosing
- [PO route]
 - CrCl <80: decr. usual start dose by 50-75%
 
- HD: start 0.5-1 mg q6h; no supplement after dialysis; PD: start 0.5-1 mg q6h; no supplement
 
- [parenteral route]
 - CrCl <80: decr. usual start dose by 50-75%
 
- HD: decr. usual start dose, amount not defined; no supplement after dialysis; PD: decr. usual start dose, amount not defined; no supplement
 
- [rectal route]
 - renal impairment: not defined, caution advised
 
- HD/PD: not defined, caution advised
 
Hepatic dosing
- [PO route]
 - Child-Pugh Class B: decr. usual start dose by 50-75%; Child-Pugh Class C: decr. usual start dose, amount not defined, titrate slowly
 
- [parenteral route]
 - Child-Pugh Class B: decr. usual start dose by 50-75%; Child-Pugh Class C: decr. usual start dose, amount not defined, titrate slowly
 
- [rectal route]
 - hepatic impairment: not defined, caution advised
 
Recommended Peds Dosing
- Dosage forms: TAB: 2 mg, 4 mg, 8 mg; SOL: 1 mg per mL; INJ (pre-filled syringe): 0.5 mg per 0.5 mL, 1 mg per mL, 2 mg per mL, 4 mg per mL
 
Pain, mod-severe
- [PO route, 6 mo and older, <50 kg]
 - Dose: 30-80 mcg/kg/dose PO q3-6h; Start: 30-80 mcg/kg/dose PO q4-6h; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if prolonged or long-term use
 
- [PO route, 6 mo and older, >50 kg]
 - Dose: 2-4 mg PO q3-6h; Start: 1-2 mg PO q4-6h; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if prolonged or long-term use
 
- [parenteral route, <6 mo]
 - Dose: 5 mcg/kg/dose SC/IV q2-6h; Start: 5 mcg/kg/dose SC/IV q4-6h; Alt: 1.5 mcg/kg/h IV; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if prolonged or long-term use
 
- [parenteral route, 6 mo and older, <50 kg]
 - Dose: 15-20 mcg/kg/dose SC/IV q2-6h; Start: 15-20 mcg/kg/dose SC/IV q4-6h; Alt: 6 mcg/kg/h IV; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if prolonged or long-term use
 
- [parenteral route, 6 mo and older, >50 kg]
 - Dose: 1-2 mg SC/IV q3-6h; Start: 1 mg SC q4-6h; 0.2-0.6 mg IV q2-4h; Alt: 0.3 mg/h IV; Info: use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if prolonged or long-term use
 
- [PCA route, <50 kg]
 - Dose: 2-5 mcg/kg/dose IV q6-20min prn; Start: 8 mcg/kg/dose IV x1; Max: 20 mcg/kg/h; Info: basal rate for opioid-experienced pts is up to 3 mcg/kg/h; dosing varies, refer to institution protocol; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if prolonged or long-term use
 
- [PCA route, >50 kg]
 - Dose: 0.05-0.4 mg IV q6-20min prn; Start: 0.1-0.5 mg IV x1; Info: basal rate for opioid-experienced pts is up to 0.5 mg/h; dosing varies, refer to institution protocol; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if prolonged or long-term use
 
Renal dosing
- [see below]
 - renal impairment: decr. usual dose, amount not defined
 
- HD/PD: not defined, caution advised
 
Hepatic dosing
- [not defined]
 - hepatic impairment: consider adult hepatic dosing for guidance
 
SRC: NLM .